Detalhe da pesquisa
1.
Design, synthesis, and evaluation of novel (E)-N'-(3-allyl-2-hydroxy)benzylidene-2-(4-oxoquinazolin-3(4H)-yl)acetohydrazides as antitumor agents.
Arch Pharm (Weinheim)
; 355(1): e2100216, 2022 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-34674294
2.
Design, synthesis and evaluation of novel 2-oxoindoline-based acetohydrazides as antitumor agents.
Sci Rep
; 12(1): 2886, 2022 02 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-35190616
3.
Novel 4-Oxoquinazoline-Based N-Hydroxypropenamides as Histone Deacetylase Inhibitors: Design, Synthesis, and Biological Evaluation.
ACS Omega
; 6(7): 4907-4920, 2021 Feb 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-33644598
4.
Design, Synthesis and Evaluation of Novel 3/4-((Substituted benzamidophenoxy) methyl)-N-hydroxybenzamides/propenamides as Histone Deacetylase Inhibitors and Antitumor Agents.
Anticancer Agents Med Chem
; 19(4): 546-556, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-30426904
5.
Novel Hydroxamic Acids Incorporating 1-((1H-1,2,3-Triazol-4-yl)methyl)- 3-substituted-2-oxoindolines: Synthesis, Biological Evaluation and SAR Analysis.
Med Chem
; 14(8): 831-850, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-29807520
6.
Inhibition of inducible nitric-oxide synthase expression by silymarin in lipopolysaccharide-stimulated macrophages.
J Pharmacol Exp Ther
; 302(1): 138-44, 2002 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-12065710